Alphatec ( (ATEC) ) has released its Q4 earnings. Here is a breakdown of the information Alphatec presented to its investors.
Alphatec Holdings, Inc., a medical device company, is dedicated to revolutionizing spine surgery through innovative solutions and operates primarily in the healthcare sector.
Alphatec Holdings reported a 27% increase in total revenue for the year 2024, reaching $612 million, and anticipates further growth in 2025 with projected revenues of approximately $732 million. The company has also achieved significant milestones, including its entry into the Japanese market.
In the fourth quarter of 2024, Alphatec saw a 28% increase in surgical revenue, driven by a 19% growth in surgical volume and a 7% rise in average revenue per surgery. The company also expanded its user base by 20% and generated $9 million in free cash flow. Despite a GAAP net loss of $33 million for the quarter, the company reported a non-GAAP adjusted EBITDA of $21 million.
Looking ahead, Alphatec expects to continue its revenue growth trajectory into 2025, with a focus on expanding its influence in the spine market through innovative technologies and operational discipline. The company aims to achieve self-funded growth and positive free cash flow in the coming year.